Search Results 331-340 of 31270 for Ovary
... ovarian cysts. Your care is provided either in the exam room or an outpatient surgical suite. A minimally invasive approach has been shown to improve ...
This is a Phase 2, open-label, single arm study to evaluate the safety and efficacy of niraparib in ovarian cancer patients who have received three or four ...
Polycystic ovary syndrome (PCOS). This condition causes a shift in the balance of sex hormones. It often starts during puberty. Over years, PCOS may slowly ...
Immune response to ovarian cancer may predict survival, Mayo-led study finds featured image. Cancer. Immune response to ovarian cancer may predict survival, ...
The purpose of this study is to compare the progression-free survival in women who have platinum-resistant ovarian cancer, who receive combination therapy ...
The study population is adult patients with asymptomatic recurrent ovarian cancer who have an elevation in their CA-125 level. Participation eligibility.
Taking into account the most common condition of androgen excess, polycystic ovary ... Of those with a diagnosis of ovarian hyperthecosis, median ovarian ...
The purpose of this study is to determine the extent to which PARP inhibitor (PARPi) treatment reduces systemic levels of mesenchymal stem cell (MSC)-derived ...
The purpose of this Phase 1a/1b study of SC-003 in patients with platinum-resistant/refractory ovarian cancer is to characterize the safety and tolerability ...
Polycystic ovary syndrome (PCOS). This condition, which often begins with puberty, causes an imbalance of sex hormones. · Cushing syndrome. This occurs when your ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.